CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for THC Farmaceuticals Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

THC Farmaceuticals Inc
7170 E McDonald Dr Ste 3
Phone: (480) 725-9060p:480 725-9060 SCOTTSDALE, AZ  85253-5424  United States Ticker: CBDGCBDG

This company ceased filing statements with the SEC on 11/29/2017.

Business Summary
THC Farmaceuticals, Inc. is engaged in the research and development of cannabis pharmaceutical products. The Company through its subsidiary CBDual Biotechnology Corp., a pharmaceutical start-up company focuses on developing products based on cannabidiol (CBD) and/or Tetrahydrocannabinol (THC). The Company is engaged cannabis formulations, edibles, and delivery systems of cannabis. It manufactures and markets cannabis extract products made from cannabis. The Company's facility is located in Southern California. It provides access for patients to participate in clinical trials of new medical cannabis medications, therapies, and products. The Company is focusing on the research of psilocybin for the purpose of conducting clinical trials involving the combination of genetic testing and micro-dosing of psilocybin formulations.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20209/30/2014YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President EdRosenthal 6/15/2015 6/15/2015
Director Eric J.Miller 6/15/2015 11/18/2014

Business Names
Business Name
CBDG
Charta Systems, Inc.

General Information
Outstanding Shares: 16,631,600 (As of 9/30/2020)
Shareholders: 65
Stock Exchange: OTC
Federal Tax Id: 261805170


Copyright © 2021 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, November 27, 2021